AI In Biopharmaceuticals Market, By Therapeutic Focus (Multi-indication/Platform Agnostic, Infectious Diseases & Vaccinology, Cardiometabolic Diseases, Neurology (incl. CNS disorders), Immunology & Inflammation, Rare & Genetic Diseases, and Oncology), By Technology, By Deployment, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5262
|
Published Date
May 2026
|
Pages
388
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
AI In Biopharmaceuticals market size was valued at US$ 2,506.9 Million in 2025, expanding at a CAGR of 31.9% from 2026 to 2033.
Artificial Intelligence (AI) in biopharmaceuticals refers to the application of advanced technologies such as machine learning, deep learning, and predictive analytics to analyze biological data and enhance drug discovery, development, and commercialization processes. The AI in biopharmaceuticals market is transforming pharmaceutical research, precision medicine, and drug development by improving operational efficiency, accelerating innovation, and optimizing commercialization strategies.
For instance, in 2026, according to the UK Government, the UK public sector manages more than USD 500 billion in annual spending, which is being strategically optimized to improve value, efficiency, and commercial outcomes across government departments. The strategy further highlights that approximately 6,000 commercial professionals are being upskilled and reorganized to strengthen procurement capabilities and accelerate commercialization across public sector operations. Consequently, the growing adoption of AI technologies is accelerating innovation, improving efficiency, and enhancing commercialization within the biopharmaceutical industry.
AI In Biopharmaceuticals Market- Market Dynamics
Growing Adoption of Precision Medicine Fueling Market Expansion
Major trends associated with the increasing demand for precision medicine in the AI in biopharmaceuticals market include the growing adoption of AI-driven predictive analytics to analyze genomic, clinical, and multi-omics data for personalized treatment selection. Advanced machine learning models are enabling faster identification of drug targets, improving patient stratification, and enhancing the accuracy of therapeutic outcomes.
A key factor driving the adoption of AI in the biopharmaceuticals market is the rising demand for precision medicine, fueled by the need for personalized and data-driven treatment approaches. AI technologies support the analysis of complex genomic and clinical datasets, thereby enhancing drug discovery processes, improving treatment precision, and optimizing patient outcomes. For instance, according to National Institutes of Health research, precision medicine studies included the analysis of 72 real-world studies. Out of 440 initially identified publications, 368 were excluded during the screening process, resulting in a final evidence base of 72 studies for detailed analysis.
The findings revealed that approximately 67% of the studies focused on cancer-related precision medicine technologies, while the remaining 33% addressed non-cancer conditions, including metabolic, neurological, and pharmacogenomic disorders. Consequently, the growing adoption of precision medicine is significantly accelerating the integration of AI technologies within the biopharmaceutical industry.
AI In Biopharmaceuticals Market- Segmentation Analysis:
The Global AI In Biopharmaceuticals Market is segmented on the basis of Therapeutic Focus, Technology, Deployment, Application, and Region.
Based on therapeutic focus, oncology accounts for a significant share of the AI in biopharmaceuticals market due to the widespread adoption of AI technologies in cancer research, drug discovery, and precision medicine development. According to the United States Government, AI is increasingly being integrated into oncology workflows, particularly in areas such as medical imaging, radiotherapy, chemotherapy, immunotherapy, and precision oncology applications. Survey findings indicate that nearly 95% of oncology practitioners recognize AI’s role in improving diagnostic accuracy, while approximately 89% report enhanced clinical decision-making capabilities. In addition, around 60% of respondents highlighted AI’s benefits in treatment management and patient follow-up. Consequently, the growing adoption of AI technologies is improving cancer diagnosis, treatment effectiveness, and patient outcomes in oncology.
Based on technology, deep learning and computer vision hold a significant share in the AI in biopharmaceuticals market due to their ability to support advanced pattern recognition, medical imaging analysis, and predictive modeling for drug discovery and pharmaceutical research. For instance, according to research published by Ejournals.org in 2025, deep learning has become a foundational technology for modern AI systems. The global deep learning market was valued at approximately USD 10.2 billion and is projected to reach nearly USD 93.8 billion, reflecting rapid technological adoption across multiple industries. The report further highlights that advancements in computational power and increased access to large-scale datasets are accelerating the adoption of deep learning technologies across healthcare, automotive, natural language processing (NLP), and computer vision applications. Therefore, the rapid growth of deep learning technologies is driving innovation and accelerating research advancements in the biopharmaceutical industry.
AI In Biopharmaceuticals Market- Geographical Insights
North America holds a leading position in the AI in biopharmaceuticals market due to the widespread adoption of artificial intelligence, advanced healthcare infrastructure, strong cloud computing capabilities, and substantial investments in AI research and laboratory development. For instance, in 2026, according to the Federal Reserve, AI adoption across the U.S. economy continued to expand rapidly through 2025. The report indicates that approximately 18% of U.S. firms had adopted AI by the end of 2025, while around 20% expected to adopt AI in the first half of 2026. In addition, work-related generative AI adoption reached nearly 41% of the U.S. workforce in November 2025, and about 50% of the population reported using generative AI for non-work purposes. Consequently, the growing adoption of AI technologies is accelerating biopharmaceutical innovation across North America.
In contrast, the Asia-Pacific region is experiencing rapid growth in the AI in biopharmaceuticals market, driven by expanding biopharmaceutical research activities and increasing investments in advanced healthcare technologies. For instance, according to Trade.gov, Japan’s medical device market is valued at approximately USD 26 billion, reflecting significant investment in advanced healthcare technologies and digital medical infrastructure. The report further highlights that the Japanese government is actively promoting innovation through initiatives such as Software as a Medical Device (SaMD), AI-based diagnostics, IoT-enabled healthcare solutions, and robot-assisted medical devices under the DASH for SaMD strategy. As a result, ongoing advancements in healthcare infrastructure are accelerating the adoption of AI-driven biopharmaceutical solutions across the Asia-Pacific region.
Italy AI In Biopharmaceuticals Market- Country Insights
The AI in biopharmaceuticals market in Italy is supported by a well-established healthcare system and an increasing focus on digital healthcare transformation. For instance, in 2025, according to research by National Institutes of Health, Italy’s healthcare sector is undergoing rapid digitalization driven by national recovery investments and the widespread adoption of electronic health systems. The study highlights that Italy has invested approximately €2,470 million in digital health, with more than 50% of general practitioners using telemedicine services and around 41% of citizens engaging with electronic health records. It also reports rising adoption of generative AI tools, with about 46% of general practitioners and 26% of specialists using AI to support clinical and administrative workflows. Consequently, the ongoing digital transformation of healthcare is accelerating AI adoption in Italy’s biopharmaceutical sector.
AI In Biopharmaceuticals Market- Competitive Landscape:
The AI in biopharmaceuticals market is moderately consolidated, with competition driven by advancements in AI-enabled drug discovery, molecular design, and precision therapeutics development. Key players include Insilico Medicine, Exscientia, Atomwise, BenevolentAI, and Recursion Pharmaceuticals, which are actively leveraging AI platforms to accelerate drug discovery and optimize R&D pipelines. For instance, in June 2025, BenevolentAI expanded its AI-powered drug development pipeline through enhanced knowledge graph-based systems and machine learning models, enabling faster identification of therapeutic targets for complex diseases. As a result, continuous AI innovation is improving drug discovery efficiency and accelerating biopharmaceutical development.
Recent Developments
- In July 2025, Recursion Pharmaceuticals announced continued investment of approximately USD 150 million in its AI-enabled drug discovery infrastructure, focusing on scaling automated experimentation and predictive biology platforms to accelerate clinical research.
- In April 2025, Exscientia advanced its precision medicine pipeline by expanding AI-driven small molecule design systems and improving predictive modeling accuracy for drug discovery and clinical candidate selection.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL AI IN BIOPHARMACEUTICALS MARKETKEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Insilico Medicine
- Exscientia
- Atomwise
- BenevolentAI
- Recursion Pharmaceuticals
- Schrödinger
- Deep Genomics
- Relay Therapeutics
- Valo Health
- Numerate
- BenchSci
- Owkin
- Causal AI (BioSymetrics)
- Cloud Pharmaceuticals
- Healx
- PathAI
- Tempus
- GNS Healthcare
- DeepMind (Google DeepMind)
- IBM Watson Health
- Others
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY THERAPEUTIC FOCUS- MARKET ANALYSIS, 2020 - 2033
- Multi-indication/Platform Agnostic
- Infectious Diseases & Vaccinology
- Cardiometabolic Diseases
- Neurology (incl. CNS disorders)
- Immunology & Inflammation
- Rare & Genetic Diseases
- Oncology
- Others
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Hybrid & Multi-omics Integration Models
- Computer Vision (histopathology, imaging analysis)
- NLP for Literature & Regulatory Mining
- Generative Models (transformers, diffusion models for molecule generation)
- Deep Learning (CNNs, RNNs)
- Classical Machine Learning (random forests, gradient boosting)
- Others
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY DEPLOYMENT- MARKET ANALYSIS, 2020 - 2033
- Hybrid (cloud + on-prem orchestration)
- Edge/Embedded (lab instruments, imaging devices)
- On-premise/Private Cloud (regulated environments)
- Cloud-based SaaS & Platforms
- Ohers
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Commercial & Market Access Analytics (RWE, pricing, HCP/patient engagement models)
- Regulatory Intelligence & Pharmacovigilance (signal detection, dossier automation)
- Manufacturing & Bioprocess Optimization (PAT, yield prediction, predictive maintenance)
- Clinical Development & Trials (trial design, cohort selection, digital biomarkers)
- Preclinical Development (toxicity prediction, ADME modeling)
- Drug Discovery (target identification, virtual screening, lead optimization)
- Others
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. AI In Biopharmaceuticals Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. AI In Biopharmaceuticals Market Snippet by Therapeutic Focus
2.1.2. AI In Biopharmaceuticals Market Snippet by Technology
2.1.3. AI In Biopharmaceuticals Market Snippet by Deployment
2.1.4. AI In Biopharmaceuticals Market Snippet by Application
2.1.5. AI In Biopharmaceuticals Market Snippet by Country
2.1.6. AI In Biopharmaceuticals Market Snippet by Region
2.2. Competitive Insights
3. AI In Biopharmaceuticals Key Market Trends
3.1. AI In Biopharmaceuticals Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. AI In Biopharmaceuticals Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. AI In Biopharmaceuticals Market Opportunities
3.4. AI In Biopharmaceuticals Market Future Trends
4. AI In Biopharmaceuticals Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. AI In Biopharmaceuticals Market : Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. AI In Biopharmaceuticals Market Landscape
6.1. AI In Biopharmaceuticals Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. AI In Biopharmaceuticals Market – By Therapeutic Focus
7.1. Overview
7.1.1. Segment Share Analysis, By Therapeutic Focus, 2025 & 2033 (%)
7.1.2. Multi-indication/Platform Agnostic
7.1.3. Infectious Diseases & Vaccinology
7.1.4. Cardiometabolic Diseases
7.1.5. Neurology (incl. CNS disorders)
7.1.6. Immunology & Inflammation
7.1.7. Rare & Genetic Diseases
7.1.8. Oncology
7.1.9. Others
8. AI In Biopharmaceuticals Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
8.1.2. Hybrid & Multi-omics Integration Models
8.1.3. Computer Vision (histopathology, imaging analysis)
8.1.4. NLP for Literature & Regulatory Mining
8.1.5. Generative Models (transformers, diffusion models for molecule generation)
8.1.6. Deep Learning (CNNs, RNNs)
8.1.7. Classical Machine Learning (random forests, gradient boosting)
8.1.8. Others
9. AI In Biopharmaceuticals Market – By Deployment
9.1. Overview
9.1.1. Segment Share Analysis, By Deployment, 2025 & 2033 (%)
9.1.2. Hybrid (cloud + on-prem orchestration)
9.1.3. Edge/Embedded (lab instruments, imaging devices)
9.1.4. On-premise/Private Cloud (regulated environments)
9.1.5. Cloud-based SaaS & Platforms
9.1.6. Others
10. AI In Biopharmaceuticals Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
10.1.2. Commercial & Market Access Analytics (RWE, pricing, HCP/patient engagement models)
10.1.3. Regulatory Intelligence & Pharmacovigilance (signal detection, dossier automation)
10.1.4. Manufacturing & Bioprocess Optimization (PAT, yield prediction, predictive maintenance)
10.1.5. Clinical Development & Trials (trial design, cohort selection, digital biomarkers)
10.1.6. Preclinical Development (toxicity prediction, ADME modeling)
10.1.7. Drug Discovery (target identification, virtual screening, lead optimization)
10.1.8. Others
11. AI In Biopharmaceuticals Market – By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. AI In Biopharmaceuticals Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. AI In Biopharmaceuticals Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. AI In Biopharmaceuticals Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. AI In Biopharmaceuticals Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. AI In Biopharmaceuticals Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Therapeutic Focus, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Deployment, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- AI In Biopharmaceuticals Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Insilico Medicine
12.2.2. Exscientia
12.2.3. Atomwise
12.2.4. BenevolentAI
12.2.5. Recursion Pharmaceuticals
12.2.6. Schrödinger
12.2.7. Deep Genomics
12.2.8. Relay Therapeutics
12.2.9. Valo Health
12.2.10. Numerate
12.2.11. BenchSci
12.2.12. Owkin
12.2.13. Causal AI (BioSymetrics)
12.2.14. Cloud Pharmaceuticals
12.2.15. Healx
12.2.16. PathAI
12.2.17. Tempus
12.2.18. GNS Healthcare
12.2.19. DeepMind (Google DeepMind)
12.2.20. IBM Watson Health
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL AI IN BIOPHARMACEUTICALS MARKETKEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Insilico Medicine
- Exscientia
- Atomwise
- BenevolentAI
- Recursion Pharmaceuticals
- Schrödinger
- Deep Genomics
- Relay Therapeutics
- Valo Health
- Numerate
- BenchSci
- Owkin
- Causal AI (BioSymetrics)
- Cloud Pharmaceuticals
- Healx
- PathAI
- Tempus
- GNS Healthcare
- DeepMind (Google DeepMind)
- IBM Watson Health
- Others
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY THERAPEUTIC FOCUS- MARKET ANALYSIS, 2020 - 2033
- Multi-indication/Platform Agnostic
- Infectious Diseases & Vaccinology
- Cardiometabolic Diseases
- Neurology (incl. CNS disorders)
- Immunology & Inflammation
- Rare & Genetic Diseases
- Oncology
- Others
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Hybrid & Multi-omics Integration Models
- Computer Vision (histopathology, imaging analysis)
- NLP for Literature & Regulatory Mining
- Generative Models (transformers, diffusion models for molecule generation)
- Deep Learning (CNNs, RNNs)
- Classical Machine Learning (random forests, gradient boosting)
- Others
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY DEPLOYMENT- MARKET ANALYSIS, 2020 - 2033
- Hybrid (cloud + on-prem orchestration)
- Edge/Embedded (lab instruments, imaging devices)
- On-premise/Private Cloud (regulated environments)
- Cloud-based SaaS & Platforms
- Ohers
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Commercial & Market Access Analytics (RWE, pricing, HCP/patient engagement models)
- Regulatory Intelligence & Pharmacovigilance (signal detection, dossier automation)
- Manufacturing & Bioprocess Optimization (PAT, yield prediction, predictive maintenance)
- Clinical Development & Trials (trial design, cohort selection, digital biomarkers)
- Preclinical Development (toxicity prediction, ADME modeling)
- Drug Discovery (target identification, virtual screening, lead optimization)
- Others
GLOBAL AI IN BIOPHARMACEUTICALS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
